The National Times - Trump nominates former US Fed official as next central bank chief

Trump nominates former US Fed official as next central bank chief


Trump nominates former US Fed official as next central bank chief
Trump nominates former US Fed official as next central bank chief / Photo: © GETTY IMAGES NORTH AMERICA/AFP

US President Donald Trump announced Friday that he is nominating Kevin Warsh, a former Federal Reserve governor, to be the next US central bank chief.

Change text size:

Trump's decision caps a closely watched search for a successor to current Fed Chair Jerome Powell, whom the president has repeatedly lambasted for not cutting interest rates more swiftly.

"I have known Kevin for a long period of time, and have no doubt that he will go down as one of the GREAT Fed Chairmen, maybe the best," Trump wrote on his Truth Social platform.

"On top of everything else, he is 'central casting,' and he will never let you down," the US leader added.

Powell's term at the helm ends in May.

The president's selection ends a race that had narrowed to four contenders -- Warsh; current Fed governor Christopher Waller; Rick Rieder of BlackRock; and Trump's top economic adviser Kevin Hassett.

But Warsh will need to be confirmed by the US Senate, facing questions by lawmakers on both sides of the aisle.

If given the green light, he is also set to take the Fed chief role at a time when the Trump administration has sharply escalated pressure on the independent central bank.

Trump's recent moves have sparked worries about the Fed's insulation from politics, which if eroded could have ramifications for the world's biggest economy, experts warn.

Warsh, who is from New York, has recently stepped up his criticism of the Fed, endorsing many of the policy positions of Trump and his administration.

He used to be a mergers and acquisitions banker at Morgan Stanley.

In Trump's first term, the president considered Warsh for the Fed Chair position as well -- replacing Janet Yellen -- but eventually chose Powell.

As Trump continues to call for lower interest rates to boost the economy, all eyes will be on how Warsh defends the bank's independence in the face of politics.

Already, Trump has sought to fire Fed Governor Lisa Cook over claims of mortgage fraud, sparking a legal battle likely to prove crucial in determining how much discretion the president has when it comes to removing key central bank officials.

The Trump administration has also launched an investigation into Powell over renovations at the Fed's headquarters, in a probe that Powell has slammed as a threat to the bank's independence.

The next Fed chairman will need to convince financial markets and policymakers that he is upholding the bank's dual mandate of stable prices and low unemployment independently of politics, analysts believe.

But this job is becoming increasingly challenging as Trump's tariffs over the past year have fueled worries of stubborn inflation, while the employment market has cooled.

The situation has left Fed policymakers walking a tightrope as they adjust interest rates, deciding if they should keep levels higher to curb inflation or lower them to boost the world's biggest economy.

R.Hawkins--TNT

Featured

Carney touts Canada 'pivot' away from US as Trump levels new threat

Canadian Prime Minister Mark Carney said Tuesday that reducing economic ties with the United States would come at a cost but the benefits were clear, as President Donald Trump threatened new penalties targeting Canada.

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Change text size: